Risk factors for eye complications in patients with diabetes mellitus: Development and progression

Eastern Mediterranean Health Journal

Volumn 6, Issue 2-3, 2000, Pages 313-325

  El Shazly, M ^a   Zeid, M ^b   Osman, A ^b  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; DIABETIC RETINOPATHY; DISEASE COURSE; EGYPT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SOCIOECONOMICS; STATISTICAL MODEL; TIME;

ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; EGYPT; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 0034157962     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Klein R, Klein BEK. Vision disorders in diabetes. In: National Diabetes Data Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. Diabetes in America, 2nd ed. Washington DC, Government Printing Office, 1995:293-338.
2. Nicolosi A et al. Prevalence and causes of visual impairment in Italy. International journal of epidemiology, 1994, 23:359-64.
3. Kohner EM. Diabetic eye disease. In: Keen H, Jarrett RJ, eds. Complications of diabetes. London, Edward Arnold, 1982:19-108.
4. Klein R et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression ofdiabetic retinopathy. Archives of ophthalmology, 1994, 112:121-8.
5. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic medicine, 1997, 14(suppl. 5):S1-85.
6. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood glucose control on late complications of type I diabetes. Lancet, 1993, 341(8856):1306-9.
7. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England journal of medicine, 1993, 329:977-9.
8. Kaplan SH, Greenfield S, Ware J. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Medical care, 1989, 27(3 suppl.):S110-27.
9. Greenfield S, Nelson EC. Recent development and future issues in the use of health status assessment measures in clinical settings. Medical care, 1992, 30(5 suppl.):MS23-41.
10. Pringle M et al. Influences on control in diabetes mellitus: patients, doctor, practice or delivery care? British medical journal, 1993, 306:630-4.
11. Bradley C, Marteau TM. Towards an integration of psychological and medical perspectives of diabetes management. In: Alberti KGMM, Krall LP, eds. The diabetes annual. London, Elsevier, 1986.
12. Tudor S et al. Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. Diabetes care, 1998, 21(1):53-61.
13. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the Modified Airlie House classification. ETDRS report number 10. Early Treatment Retinopathy Study Research Group. Ophthalmology, 1991, 98:786-806.
14. The fifth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Bethesda, Maryland, National Heart, Lung, and Blood Institute, National Institutes of Health, 1993.
15. Schlesselman JJ. Case-control studies. Design, conduct and analysis. New York, Oxford University Press, 1982.
16. Hosmer DW, Lemeshow S. Applied logistic regression. New York, John Wiley and Sons, 1989.
17. House JS, Robbins C, Metzner HL. The association of social relationships and activities with mortality: prospective evidence from the Tecumseh Community Health Study. American journal of epidemiology, 1982, 116:123-40.
18. Broadhead WE et al. The epidemiological evidence for a relationship between social support and health. American journal of epidemiology, 1983, 117:521-37.
19. Straub R et al. Impact of disease duration on cardiovascular and pupillary autonomic nervous function in IDDM and NIDDM patients. Diabetes care, 1996, 19(9):960-7.
20. Grenfell A, Watkin PJ. Clinical diabetic nephropathy: natural history and complications. Clinics in endocrinology and metabolism, 1986, (15):783-805.
21. Watkin PW, Drury PL, Taylor KW. An overview of complications. In: Watkins P, Drury P, eds. Diabetes and its management, 5th ed. Oxford, Blackwell Scientific Publications, 1996.
22. DCCT Research Group. The relation of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes, 1995, 44:968-83.
23. Collins V et al. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa. Diabetes care, 1995, 18(8):1140-9.
24. Chen M et al. Incidence and prevalence of diabetic retinopathy among non-insulin dependent diabetic subjects: 4-year follow-up. International journal of epidemiology, 1995, 24(4):787-95.
25. Nakagami Y et al. Glycemic control and prevention of retinopathy in Japanese NIDDM patients. A 10-year follow-up study. Diabetes care, 1997, 20(4):621-2.
26. Klein R, Klein BEK, Moss SE. Relation of glycemic control to diabetes microvascular complications in diabetes mellitus. Annals of internal medicine, 1996, 124(1 part 2):90-6.
27. National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes. Hypertension, 1994, 23(2):145-58.
28. Keen H. The prevalence of blindness in diabetics. Journal of the Royal College of Physicians, 1972, 7:53-60.
29. Klein R et al. Is blood pressure a predictor of incidence or progression of diabetic retinopathy? Archives of internal medicine, 1989, 149:2427-32.
30. Krolewski AS, Warram JH, Rand Ll. Risk of proliferative diabetic retinopathy in juvenile onset type I diabetes: 40-year follow-up study. Diabetes care, 1986, 9:443-52.
31. Stephenson JM et al. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia, 1995, 38:599-603.
32. Krolewski AS, Warram JHR, Khan CR. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. New England journal of medicine, 1987, 317:1390-8.
33. Chaturvedi N, Stephenson J, Fuller J. The relation between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diabetes care, 1995, 18(6):785-92.
34. Paetkau ME et al. Cigarette smoking and diabetic retinopathy. Diabetes, 1977, 26:46-9.
35. Moss SE, Klein R, Klein BEK. Association of cigarette smoking with diabetic retinopathy. Diabetes care, 1991, 14:119-26.
36. Orchard TJ et al. Factors associated with avoidance of severe complications after 25 years of IDDM: Pittsburgh Epidemiology of Diabetes Complications Study 1. Diabetes care, 1990, 13:741-7.